US FDA has withdrawn the approval of the NDA for Wellcovorin, at the request of GSK (GSK LN)
Importance
Level 1
#UNITED KINGDOM#EUROPE#GLAXOSMITHKLINE PLC#GSK.LN#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100 INDEX#GSK PLC#GSK#FTSE 100